Literature DB >> 8495401

Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells.

G P Siegal1, M H Wang, C A Rinehart, J W Kennedy, L J Goodly, Y Miller, D G Kaufman, R K Singh.   

Abstract

During the crucial stages of tumor cell invasion and metastasis, neoplastic cells must traverse extracellular matrices for their migration to distant sites. Because basement membranes (BM) serve as a critical barrier to such passages, most previous in vitro assay models have utilized either an intact BM or a reconstituted rodent or avian BM-matrix to study this process. We have created a gel-like extracellular matrix derived from human amnions which contained type IV collagen, laminin, entactin, tenascin and heparan sulfate proteoglycan. This matrix, which we called Amgel, was used to study selected steps of invasion including cell attachment to matrix, degradation of it by proteolytic enzymes and movement of human tumor cells through matrix defects. An efficient tumor invasion assay system was developed utilizing filter-supported uniform coatings of this matrix in chambers. Human tumor cells (HT-1080 fibrosarcoma and RL-95 adenocarcinoma), when seeded onto Amgel-coated membranes, attached to matrix within 2 h and initiated a time-dependent migration and invasion process, as verified by biochemical analysis and both light and electron microscopy. In an optimized invasion assay 12-15% of tumor cells completely traversed the matrix during a 72-h period with > 90% viability. In contrast to these highly-invasive cells, normal human foreskin fibroblasts and normal human endometrial stromal cells exhibited minimal migration/matrix penetration during the same time period. When the Amgel-selected tumor cells (i.e. those penetrating the barrier) were isolated, subcultured, and re-exposed to Amgel, they had heightened invasiveness (2-3-fold) as compared to the parental cells. Thus, this improved 'all human' system for quantitating the invasive ability of tumor cells may provide a valuable tool in dissecting out the mechanistic underpinnings of human metastasis. In addition, this assay has the ability to screen agents which have potential anti-invasive and by extension anti-metastatic, activity or chemotactic properties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495401     DOI: 10.1016/0304-3835(93)90164-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells.

Authors:  Mohamed Osman; Micky Tortorella; Marco Londei; Sonia Quaratino
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

Review 2.  Reviewing and reconsidering invasion assays in head and neck cancer.

Authors:  Ronald C Inglehart; Christina S Scanlon; Nisha J D'Silva
Journal:  Oral Oncol       Date:  2014-10-14       Impact factor: 5.337

3.  Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44.

Authors:  M Zhang; R K Singh; M H Wang; A Wells; G P Siegal
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

4.  The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle.

Authors:  Sara Hinds; Weining Bian; Robert G Dennis; Nenad Bursac
Journal:  Biomaterials       Date:  2011-02-13       Impact factor: 12.479

5.  Engineered skeletal muscle tissue networks with controllable architecture.

Authors:  Weining Bian; Nenad Bursac
Journal:  Biomaterials       Date:  2008-12-12       Impact factor: 12.479

6.  In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.

Authors:  H Xie; T Turner; M H Wang; R K Singh; G P Siegal; A Wells
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

Review 7.  Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms.

Authors:  A Albini
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

8.  Cell surface associated alpha-L-fucose moieties modulate human breast cancer neoplastic progression.

Authors:  Kun Yuan; Catherine M Listinsky; Raj K Singh; Jay J Listinsky; Gene P Siegal
Journal:  Pathol Oncol Res       Date:  2008-06-13       Impact factor: 3.201

9.  IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity.

Authors:  H Shiraha; A Glading; K Gupta; A Wells
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

10.  Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer.

Authors:  Miranda Y Fong; Shunying Jin; Madhavi Rane; Raj K Singh; Ramesh Gupta; Sham S Kakar
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.